Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $712.71 | 8 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $301.64 | 3 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $137.41 | 2 | $0 (2024) |
| UCB, Inc. | $125.00 | 1 | $0 (2024) |
| La Jolla Pharmaceutical Company | $123.34 | 1 | $0 (2023) |
| Amgen Inc. | $25.32 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $247.28 | 2 | UCB, Inc. ($125.00) |
| 2023 | $255.45 | 3 | La Jolla Pharmaceutical Company ($123.34) |
| 2022 | $209.98 | 3 | GlaxoSmithKline, LLC. ($194.85) |
All Payment Transactions
8 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Immunology | ||||||
| 02/29/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $122.28 | General |
| Category: Respiratory | ||||||
| 10/03/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $106.79 | General |
| Category: RESPIRATORY | ||||||
| 06/02/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $25.32 | General |
| Category: Cardiology | ||||||
| 05/02/2023 | La Jolla Pharmaceutical Company | XERAVA (Drug) | Food and Beverage | In-kind items and services | $123.34 | General |
| Category: TETRACYCLINE CLASS ANTIBACTERIAL | ||||||
| 05/19/2022 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $69.85 | General |
| Category: IMMUNOLOGY | ||||||
| 05/11/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: RESPIRATORY | ||||||
| 04/18/2022 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $15.13 | General |
About Dr. Javier Rios, MD
Dr. Javier Rios, MD is a Rheumatology healthcare provider based in Salt Lake City, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/29/2021. The National Provider Identifier (NPI) number assigned to this provider is 1114504693.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Javier Rios, MD has received a total of $712.71 in payments from pharmaceutical and medical device companies, with $247.28 received in 2024. These payments were reported across 8 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($712.71).
Practice Information
- Specialty Rheumatology
- Location Salt Lake City, UT
- Active Since 03/29/2021
- Last Updated 04/03/2024
- Taxonomy Code 207RR0500X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1114504693
Products in Payments
- Bimzelx (Biological) $125.00
- TRELEGY ELLIPTA (Drug) $125.00
- XERAVA (Drug) $123.34
- AIRSUPRA (Drug) $122.28
- AREXVY (Drug) $106.79
- NUCALA (Biological) $69.85
- Repatha (Biological) $25.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Salt Lake City
Curry Koening, M.d, M.D
Rheumatology — Payments: $40,179
Daniel Clegg, Md, MD
Rheumatology — Payments: $14,846
Dr. Grant Cannon, M.d, M.D
Rheumatology — Payments: $6,819
Tawnie Braaten, M.d, M.D
Rheumatology — Payments: $871.32
Swetha Ann Alexander, Mbbs, MBBS
Rheumatology — Payments: $316.64
Dr. Julie Thomas, M.d, M.D
Rheumatology — Payments: $157.53